Inicio › Cáncer de ovario › Wisconsin
Ensayos clínicos de Cáncer de ovario en Wisconsin
29 estudios sobre Cáncer de ovario buscan participantes en Wisconsin.
Ciudades en Wisconsin
- Milwaukee17 estudios
- Madison13 estudios
- Green Bay5 estudios
- Manitowoc3 estudios
- Sheboygan3 estudios
- La Crosse3 estudios
- Oshkosh3 estudios
- Kenosha3 estudios
- Racine3 estudios
Texto oficial del estudio (inglés)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- ThedaCare Regional Cancer Center, Appleton
- ThedaCare Regional Medical Center - Appleton, Appleton
- Duluth Clinic Ashland, Ashland
- y 42 más
ReclutandoFase 2
Todas las edades · Todos los sexos · Actualizado el 2 oct 2026 · NCT05564377The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Wisconsin Carbone Cancer Center, Madison
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- UW Health Carbone Cancer Center, Madison
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06760819A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Milwaukee
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT05877599Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- Mayo Clinic Health System - Northwest Wisconsin, Eau Claire
- Mayo Clinic Health System - Southwest Wisconsin, La Crosse
ReclutandoEstudio observacional
Edades de 18 en adelante · Mujeres · Actualizado el 29 sept 2026 · NCT05051722Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Research Site, Madison
ReclutandoFase 2
Edades de 18 a 130 · Todos los sexos · Actualizado el 23 sept 2026 · NCT05489211A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07213804A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- University of Wisconsin - Carbone Cancer Center, Madison
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07213791A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Froedtert & MCW Cancer Center, Milwaukee
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07109726Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
- Froedtert and The Medical College of Wisconsin, Milwaukee
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 15 sept 2026 · NCT06915025A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Froedtert & the Medical College of Wisconsin, Milwaukee
ReclutandoFase 2
Edades de 18 a 99 · Mujeres · Actualizado el 15 sept 2026 · NCT07023627Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Prohealth Care, Waukesha
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 15 sept 2026 · NCT07214779Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
- University of Wisconsin, Madison
- Medical College of Wisconsin, Milwaukee
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 14 sept 2026 · NCT06787612ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- ThedaCare Regional Cancer Center, Appleton
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT05059444The Vanguard Study: Testing a New Way to Screen for Cancer
- Zablocki Veterans Administration Medical Center, Milwaukee
ReclutandoSe aceptan voluntarios sanos
Edades de 45 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT06995898Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer
- ProHealth Care Inc, Waukesha
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 1 sept 2026 · NCT07564141Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 ago 2026 · NCT06582017Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic Cancers
- UW Carbone Cancer Center, Madison
ReclutandoEstudio observacional
Edades de 18 en adelante · Mujeres · Actualizado el 27 ago 2026 · NCT07125209Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
- Marshfield Medical Center-Marshfield, Marshfield
- y 6 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT07001748A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Aurora Cancer Care-Southern Lakes VLCC, Burlington
- Aurora Saint Luke's South Shore, Cudahy
- Aurora Health Care Germantown Health Center, Germantown
- y 20 más
Reclutando
Edades de 35 a 50 · Mujeres · Actualizado el 7 ago 2026 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Duluth Clinic Ashland, Ashland
- Northwest Wisconsin Cancer Center, Ashland
- Aurora Cancer Care-Southern Lakes VLCC, Burlington
- y 33 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 ago 2026 · NCT06580314A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Froedtert and the Medical College of Wisconsin, Milwaukee
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 jul 2026 · NCT06161025Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 121, Milwaukee
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 16 jul 2026 · NCT06906341An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
- University of Wisconsin - Carbone Cancer Center - University Hospital, Madison
ReclutandoFase 2
Edades de 18 a 100 · Mujeres · Actualizado el 13 jul 2026 · NCT05887609Lead-212 PSV359 Therapy for Patients With Solid Tumors
- University of Wisconsin, Madison
ReclutandoFase 1/2
Edades de 18 a 90 · Todos los sexos · Actualizado el 6 jul 2026 · NCT06710756Integrated Cancer Repository for Cancer Research
- Bellin Memorial Hospital, Green Bay
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 19 a 110 · Todos los sexos · Actualizado el 29 jun 2026 · NCT02012699SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
- University of Wisconsin Carbone Cancer Center, Madison
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 jun 2026 · NCT05568680Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- Froedtert Memorial Lutheran Hospital & Medical College of Wisconsin, Milwaukee
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 16 abr 2026 · NCT05659381SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Milwaukee
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.